STOCK TITAN

Indivior Pharmaceuticals (INDV) Stock News, Jun 2023-Feb 2024

INDV NASDAQ

Ticker history: INDV became SUPN (Indivior Pharmaceuticals, Inc.) on .

Indivior Pharmaceuticals, Inc. reports developments in specialty pharmaceuticals for opioid use disorder, with recurring updates centered on SUBLOCADE, its monthly extended-release buprenorphine injection, and evidence supporting medications for opioid use disorder. Company news commonly covers financial results and guidance, commercial performance for SUBLOCADE, scientific and real-world evidence studies, and treatment-use discussions in settings such as correctional facilities.

Indivior updates also include capital-allocation actions, including share repurchase programs and convertible note financing, along with corporate presentations and investor communications tied to the Indivior Action Agenda. The company’s disclosures frame opioid use disorder as a chronic treatable brain disease and emphasize buprenorphine-based prescription treatments.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
21.71%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.47%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.50%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.19%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.05%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.65%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.71%
Tags
none

FAQ

What is the current stock price of Indivior Pharmaceuticals (INDV)?

Indivior Pharmaceuticals (INDV) last closed at $36.28. The company now trades as SUPN.